Quinolones In Typhoid Fever

dc.date.accessioned2022-10-09T17:42:33Z
dc.date.available2022-10-09T17:42:33Z
dc.date.created2022-10-09T17:42:33Z
dc.date.issued1994
dc.identifierhttps://hdl.handle.net/20.500.12866/12281
dc.identifierhttps://doi.org/10.1097/00019048-199409000-00004
dc.description.abstractIn the pre-antibiotic era, typhoid fever presented an evolving course of high fever, malaise, and headache...
dc.languageeng
dc.publisherWolters Kluwer Health
dc.relationInfectious Diseases in Clinical Practice
dc.relation1536-9943
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHuman
dc.subjectchloramphenicol
dc.subjectciprofloxacin
dc.subjectintravenous drug administration
dc.subjectlomefloxacin
dc.subjectnorfloxacin
dc.subjectoral drug administration
dc.subjectquinoline derived antiinfective agent
dc.subjectreview
dc.subjectamoxicillin
dc.subjectampicillin
dc.subjectclinical trial
dc.subjectcost
dc.subjectenoxacin
dc.subjectfleroxacin
dc.subjectofloxacin
dc.subjectpefloxacin
dc.subjectquinolone
dc.subjectsalmonella paratyphi
dc.subjectsalmonella typhi
dc.subjectsulfamethoxazole
dc.subjecttrimethoprim
dc.subjecttyphoid fever
dc.titleQuinolones In Typhoid Fever
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución